This presentation introduces the need for new visceral leishmaniasis treatments, and describes DNDi's work to find new classes of drug (e.g. boron compounds) and new formulations of amphotericin B.
Presentation from ‘Challenges for and Potential in the Early-Stage R&D Pipeline to Develop New Antileishmanial Drugs. Symposium held at World Leish 4, Lucknow, India, 4 February 2009.
Current and Emerging Approaches in Antileishmanial Research.